Ignite Creation Date:
2024-05-06 @ 6:44 PM
Last Modification Date:
2024-10-26 @ 2:53 PM
Study NCT ID:
NCT05766748
Status:
RECRUITING
Last Update Posted:
2024-06-14
First Post:
2023-02-24
Brief Title:
Study of Effect of Azeliragon in Patients Refractory to Prior Treatment of Metastatic Pancreatic Cancer
Sponsor:
Organization:
Cantex Pharmaceuticals